GRAIL Poaches New CEO From Roche, Genentech Post author:Sam Post published:December 13, 2017 Post category:BioPharma Four months after Jeff Huber stepped down as CEO of GRAIL, the company has tapped his replacement. Source: BioSpace You Might Also Like Zoning Changes Kills Sale of Bristol-Myers Squibb's Connecticut Campus February 20, 2017 Germany's Fresenius Kabi AG Slams Down $4.3 Billion for Akorn in U.S. Expansion April 24, 2017 Why Struggling Bristol-Myers Squibb Could Take Out This Danish Biotech in Major ???500M Deal March 20, 2017
Why Struggling Bristol-Myers Squibb Could Take Out This Danish Biotech in Major ???500M Deal March 20, 2017